Incidence, clinical characteristics and outcome of congestive heart failure as the initial presentation in patients with primary hyperthyroidism.
about
HyperthyroidismContinuation of dabigatran therapy in "real-world" practice in Hong KongFrequent premature atrial complexes predict new occurrence of atrial fibrillation and adverse cardiovascular events.The correlation between left ventricular failure and right ventricular systolic dysfunction occurring in thyrotoxicosisCongestive heart failure in subjects with thyrotoxicosis in a black community.Successful surgical treatment of cardiac complication of graves disease.Echocardiographic assessment of left ventricular function in thyrotoxicosis and implications for the therapeutics of thyrotoxic cardiac diseaseCardiovascular complications secondary to Graves' disease: a prospective study from Ukraine.Impact of Antithrombotic Therapy in Atrial Fibrillation on the Presentation of Coronary Artery Disease.An unusual cause of flash pulmonary oedema.Prediction of Thromboembolic Events in Heart Failure Patients in Sinus Rhythm: The Hong Kong Heart Failure RegistryHyperthyroidism as a reversible cause of right ventricular overload and congestive heart failure.Acute renal infarction and cardioembolic stroke in a patient with atrial fibrillation and hyperthyroid-induced cardiomyopathy: a case report.Determinants of thyrotoxic cardiomyopathy recoveryEpidemiology and natural history of recovery of left ventricular function in recent onset dilated cardiomyopathiesCardiac hypertrophy and thyroid hormone signalingSevere tricuspid regurgitation and isolated right heart failure due to thyrotoxicosis.Atrial electrical and structural remodeling: implications for racial differences in atrial fibrillation.Thyroid dysfunction in the elderly.Thyroid hormones and the heart.Paradoxical euthyroid hormone profile in a case of Graves' disease with cardiac failure.Thyroid Dysfunction and Heart Failure: Mechanisms and Associations.Management of anemia in patients with congestive heart failure.Thyrotoxicosis presenting as exertional dyspnea and pulmonary hypertension: Case report and review of literature.Graves' thyrotoxicosis-induced reversible cardiomyopathy: a case reportDilated cardiomyopathy with Graves disease in a young child.Benefit of Anticoagulation Therapy in Hyperthyroidism-Related Atrial Fibrillation.Recovery following Thyroxine Treatment Withdrawal, but Not Propylthiouracil, Averts In Vivo and Ex Vivo Thyroxine-Provoked Cardiac Complications in Adult FVB/N Mice.Better adherence to antithyroid drug is associated with decreased risk of stroke in hyperthyroidism patients.Heart Failure in Thyrotoxic Cardiomopathy: Extracorporeal Membrane Oxygenation Treatment for Graves' Disease.The protective role of peroxisome proliferator-activated receptor γ coactivator-1α in hyperthyroid cardiac hypertrophy.Ethnic differences in atrial fibrillation identified using implanted cardiac devices.The CHADS2 and CHA 2DS 2-VASc scores predict new occurrence of atrial fibrillation and ischemic stroke.Preoperative management in patients with Graves' disease.Thyrotoxic Atrial Fibrillation: Factors Associated with Persistence and Risk of Ischemic Stroke.Cyclovirobuxinum D alleviates cardiac hypertrophy in hyperthyroid rats by preventing apoptosis of cardiac cells and inhibiting the p38 mitogen-activated protein kinase signaling pathway.The Importance of Framing.Thyrotoxicosis induced cardiogenic shock rescued by extracorporeal membrane oxygenation.CSI position statement on management of heart failure in India
P2860
Q27690661-4451E904-A337-4468-8402-6D446F4E9A79Q28541487-4F1F0351-4D31-4CFC-AB03-7D9AB95E0E72Q33160784-691D3153-6283-430F-84F8-643777C01CDAQ33946125-8B8D6932-4752-4388-8549-8AF76AA60F73Q34068724-D63985C8-AAA7-4B48-9027-F90F8E708A50Q34148304-EA68CADD-968F-4D3D-B5DF-D2C537908EE1Q35094312-369DA5A3-6FD7-4ACF-9600-042C0D16FC29Q35213359-2D2E5898-D8E3-411B-8050-46918679CEF7Q35670766-D90005A9-4759-46CF-BE9D-1E65BF307B03Q35974685-C3F6676F-3F2C-4880-84EE-C2DA306C9F1CQ36236408-7EFF8E77-C0B8-4AE6-A770-4FF75882F365Q36736955-43368F99-3AFB-4F98-AB0B-8F93F65E9B41Q36879710-E476B442-B039-4E61-B387-545FC0E8A8D8Q37191280-20237BA9-1BF1-4F13-9CF9-A79C1B692239Q37297342-B61B4E7B-8AD1-407B-B600-7F821090FA36Q37363137-0C836B77-C8DA-4040-B5DD-60434C5D0F94Q37387722-4E2DAE2B-B938-4287-8E3A-4FB6EFBEAAB7Q38058859-8F853B80-17C5-4A77-A6AB-E7B259DC15DAQ38084434-ECC22C54-C8D2-429B-8380-CEB85853D8F6Q38267475-C9635D00-BDE1-4004-8097-09FDC20A6BB7Q38335897-75AAAFD9-FBE9-40DA-AEA7-D081029BC7F4Q38760094-AF6A9BD4-7483-4921-A409-F7D07D0C90AFQ38990298-F15E60A1-D85B-4C78-9EE8-D53F9985E46DQ39416662-BA62E8FB-E104-437D-8C7E-8C4396328EC8Q39773457-803C268C-187B-4FD9-897B-3D6032CD7364Q40095060-C8C4A87B-E432-4F62-B945-5D8CF6B77D1DQ40653226-26260BBD-0ACF-490D-92F2-436896ECC535Q41169082-4A0EA66D-E896-4992-B048-AA7ED697C382Q41459329-717B512B-8641-4991-BA50-C62DB8BAB5F9Q41820501-A04E7869-D6DC-4B24-B6C0-A94A7BAFF2ABQ42497788-F3A280D4-4A08-41C3-A3FF-FB1EDF8CE52EQ45001870-280D3F44-C094-4DF1-A9B0-9F19D32D1FB3Q45146326-FD6C7852-4D9A-4371-87C6-4F97E9B791F8Q47122099-8F1798E8-795F-478E-A970-6B088417C06AQ48146273-EF8BE45A-297B-49A5-8D24-793433E27C4BQ52876737-E271CEB3-46F0-4AFD-9014-CCA2F11C41BDQ54964356-C9D01EEC-5094-484B-AA99-F54281DF8C3AQ55155121-2FD0109A-DD92-4E5F-92D5-CA6ECAAC4248Q57665132-D1024ADA-CA01-403B-8B59-9029C35F89BF
P2860
Incidence, clinical characteristics and outcome of congestive heart failure as the initial presentation in patients with primary hyperthyroidism.
description
2006 nî lūn-bûn
@nan
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
2006年论文
@zh
2006年论文
@zh-cn
name
Incidence, clinical characteri ...... with primary hyperthyroidism.
@ast
Incidence, clinical characteri ...... with primary hyperthyroidism.
@en
type
label
Incidence, clinical characteri ...... with primary hyperthyroidism.
@ast
Incidence, clinical characteri ...... with primary hyperthyroidism.
@en
prefLabel
Incidence, clinical characteri ...... with primary hyperthyroidism.
@ast
Incidence, clinical characteri ...... with primary hyperthyroidism.
@en
P2093
P2860
P356
P1433
P1476
Incidence, clinical characteri ...... with primary hyperthyroidism.
@en
P2093
Annie W C Kung
Chu-Pak Lau
Chun-Yip Yeung
Chung-Wah Siu
Hung-Fat Tse
P2860
P304
P356
10.1136/HRT.2006.100628
P407
P577
2006-09-27T00:00:00Z